Brigatinib Before Brain Irradiation Trial (B3i Trial)
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Brain Metastases
Related studies linked through entity extraction aliases.
Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases
- Status
- TERMINATED
- Phase
- PHASE2
Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Analyzing Preoperative Stereotactic Radiosurgery With Gamma Knife Icon for Brain Metastases
- Status
- COMPLETED
- Phase
- NA
Dosimetric Validation of Scans Generated by GAN From Pre-therapeutic MRI in Stereotactic Cerebral Radiotherapy
- Status
- COMPLETED
- Phase
- N/A
TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Patients With HER2-Positive Breast Cancer Brain Metastases
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Tislelizumab Combined With Pemetrexed/ Carboplatin in Patients With Brain Metastases of Non-squamous NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Preoperative Stereotactic Radiosurgery for Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Pre- Versus Post-operative SRS for Resectable Brain Metastases
- Status
- TERMINATED
- Phase
- PHASE3
Phase 2 Trial in Multiple Brain Metastases Outcomes With HA-SIB-WBRT
- Status
- COMPLETED
- Phase
- PHASE2
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
- Status
- COMPLETED
- Phase
- PHASE1
Single vs Multi-fraction SRS Patients on Immunotherapy
- Status
- WITHDRAWN
- Phase
- PHASE2
Preoperative SRS/SRT vs Postoperative SRS/SRT for Brain Metastases
- Status
- TERMINATED
- Phase
- NA
DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease
- Status
- COMPLETED
- Phase
- PHASE2
X-396 (Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases
- Status
- UNKNOWN
- Phase
- PHASE2
Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE)
- Status
- COMPLETED
- Phase
- PHASE2
Study to Establish the Diagnostic Performance of 18F Fluciclovine PET in Detecting Recurrent Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE3
GM1 Prophylaxis for WBRT Related Cognitive Dysfunction
- Status
- TERMINATED
- Phase
- PHASE3
Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Evaluation of the Best Treatment in Terms of Quality of Life for Patients Having a Brain Metastasis
- Status
- UNKNOWN
- Phase
- NA